To summarize, the incident rates of IFN-α-induced depression were significantly lower in EPA-, but not in DHA-treated patients (rates: 10% and 28%, respectively, vs. 30% for placebo, P = 0.037), as compared with the placebo. Here, IFNA1 is linked to depressive disorder.